InvestorsHub Logo

RSI38

03/29/20 3:06 PM

#43485 RE: RSI38 #43484

This part of the business will prove to be a very HUUUUGE deal for Nutra Pharma..... Staying on the lookout...



" Nutra Pharma, through its RectoPharm subsidiary, carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process ReceptoPharm is developing technologies for the production of drugs for HIV and multiple sclerosis (MS), and also offers small and start-up biotech companies a full range of contract research services. "




NPHC